双相同轴打印支架靶向阻断巨噬细胞SIRPα和CSF-1R通路调控肿瘤免疫抑制微环境的研究
批准号:
82102210
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
李翠笛
依托单位:
学科分类:
医用生物材料与仿生材料
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
李翠笛
中文摘要
3D打印骨修复体具有可定制外形、适合治疗分子功能化装载,有潜力用于骨肿瘤术后肿瘤复发抑制与个性化组织修复。肿瘤免疫抑制微环境基于CSF-1R通路诱导巨噬细胞表型变化是骨肿瘤复发的关键因素。申请人前期将CSF-1R抑制剂装载于3D打印钙磷基支架可调控巨噬细胞表型并减缓肿瘤生长,却未能完全抑制。研究发现,抑制剂的递送与释放方式,以及SIRPɑ通路介导的巨噬细胞吞噬抑制是影响其效用的主要原因。因此,本课题以苯硼酸修饰的聚酰胺胺树形分子为SIRPα抗体和CSF-1R抑制剂的载体构建巨噬细胞靶向递药颗粒;研发载递药颗粒复合水凝胶为缓释外相,钙磷基体系为成骨内相同轴打印构建核壳结构治疗支架。考察支架结构和对治疗分子释放等理化性能;对巨噬细胞表型和吞噬,对破骨细胞活化和成骨分化的调控作用和机理。体内考察免疫调控对肿瘤抑制的作用机制。通过课题研究,有望为骨肿瘤治疗提供新方法和新思路。
英文摘要
3D printed bone repair implants have customizable shapes and are suitable for functional loading of therapeutic molecules, which show promising potential to be used for tumor recurrence suppression and personalized tissue repair after bone tumor surgery. The changes of macrophage phenotype induced by tumor immunosuppressive microenvironment based on CSF-1R pathway is a key factor in bone tumor recurrence. Previously, the applicant regulated local macrophage phenotypes and slowed tumor growth with CSF-1R inhibitor loaded 3D printed calcium phosphate scaffolds, but failed to completely inhibit. It was found that the way the inhibitor is delivered and released, as well as SIRP pathway-mediated macrophage phagocytosis inhibition, are the major factors affecting its efficacy. Therefore, in this study, a macrophage-targeting drug delivery system would be constructed by using phenylboric acid-modified polyamide amine dendritic molecule as the carrier of SIRPα-blocking antibody and CSF-1R inhibitor. A composite hydrogel sustained releasing the drug delivery system would be developed as the external phase, and coaxial print with calcium phosphate-based system as the osteogenic internal phase to construct an immunoregulation therapeutic scaffold with core-shell structure. The structure and physicochemical properties of the scaffold, such as release behavior of therapeutic molecules, would be investigated. Regulating effects of the scaffold on phenotype change and phagocytic behavior of macrophages, activation of osteoclasts and osteogenic differentiation of stem cells, and related mechanisms would be carefully studied in vitro. Mechanisms of tumor inhibition effects of the immunoregulation scaffold would be further investigated in vivo. Through this research, it is expected to provide new ideas and methods for the treatment of bone tumors.
3D打印骨修复植入体具有可定制外形、适合治疗分子功能化装载,有潜力用于骨肿瘤术后肿瘤复发抑制与个性化组织修复。研究表明,肿瘤免疫抑制微环境基于CSF-1R和SIRPɑ通路诱导巨噬细胞M2型极化并丢失肿瘤吞噬功能是骨肿瘤复发的关键因素。相关通路阻断药物的递送与释放方式是影响其效用的主要原因。本课题结合自固化磷酸钙墨水与自主研发逐步算法辅助生物打印技术完成了仿生各向异性骨修复内核的可控制备;将载有CSF-1R通路抑制剂的多糖基缓释遮罩层组装于钙磷基内核构建了阶段性调控局部巨噬细胞极化的治疗植入体。以苯硼酸修饰的介孔二氧化硅纳米颗粒为SIRPα抗体和CSF-1R抑制剂的载体构建巨噬细胞靶向递药系统,并引入缓释外相,制备了靶向调控巨噬细胞极化和肿瘤吞噬的多功能植入体。 . 首先,完成新型逐步算法辅助生物打印技术的研发。该技术采用基于三角剖分算法优化的自适应网格生成算法,设计生成各向异性网格图案;随后,利用三角单元最优化顶点排序算法将网格图案转化为可引入生物打印机G代码命令语言系统的有序打印路径数据集,从而可结合钙磷基墨水构建仿生各向异性骨结构。这一策略普适于挤出式生物打印机和常用生物墨水,为仿生骨修复材料的定制提供了新技术和新方法。. 接着,将羟丁基壳聚糖和氧化硫酸软骨素在自固化磷酸钙内核表面层层组装,原位交联形成保护用遮罩壳层并为CSF-1R通路抑制剂(GW2580)提供结合位点。探究并明确了核壳结构支架系统在治疗前期稳定释放GW2580对巨噬细胞M2极化的调控作用,和在治疗后期对骨再生的促进作用。. 进一步的,合成富含苯硼酸基团的介孔二氧化硅纳米颗粒,其内部孔隙可高效装载GW2580,表面可基于硼氮配位键稳定结合anti-SIRPɑ抗体,从而制得靶向巨噬细胞并阻断SIRPɑ和CSF-1R通路的递药体系。该体系引入核壳结构治疗支架的缓释壳层后,能稳定的阶段性释放,有效靶向巨噬细胞,对其极化和肿瘤吞噬功能进行调控,而不影响逐渐暴露的钙磷基内核促骨再生。. 以上工作为易复发骨肿瘤术后治疗提供了一系列新方案和基础数据。
国内基金
海外基金